Wolfgang Gaebel - Publications

Affiliations: 
Department of Psychiatry Heinrich-Heine-Universitat Dusseldorf, Germany 

199 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Peterson DL, Webb CA, Keeley JW, Gaebel W, Zielasek J, Rebello TJ, Robles R, Matsumoto C, Kogan CS, Kulygina M, Farooq S, Green MF, Falkai P, Hasan A, Galderisi S, et al. The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial. Schizophrenia Research. PMID 30799218 DOI: 10.1016/j.schres.2019.02.011  0.84
2019 Kerst A, Zielasek J, Gaebel W. Smartphone applications for depression: a systematic literature review and a survey of health care professionals' attitudes towards their use in clinical practice. European Archives of Psychiatry and Clinical Neuroscience. PMID 30607530 DOI: 10.1007/s00406-018-0974-3  0.84
2018 Lehmann I, Chisholm D, Hinkov H, Höschl C, Kapócs G, Kurimay T, Lecic-Tosevski D, Nakov V, Réthelyi JM, Winkler P, Zielasek J, Gaebel W. Development of quality indicators for mental healthcare in the Danube region. Psychiatria Danubina. 30: 197-206. PMID 29930230 DOI: 10.24869/psyd.2018.197  0.84
2018 Gaebel W, Riesbeck M, Zielasek J, Kerst A, Meisenzahl-Lechner E, Köllner V, Rose M, Hofmann T, Schäfer I, Lotzin A, Briken P, Klein V, Brunner F, Keeley JW, Rebello TJ, et al. [Web-based field studies on diagnostic classification and code assignment of mental disorders: comparison of ICD-11 and ICD-10]. Fortschritte Der Neurologie-Psychiatrie. 86: 163-171. PMID 29621822 DOI: 10.1055/s-0044-100508  0.84
2018 Zielasek J, Gaebel W. [Schizophrenia and other primary psychotic disorders in ICD-11]. Fortschritte Der Neurologie-Psychiatrie. 86: 178-183. PMID 29621821 DOI: 10.1055/s-0044-101832  0.84
2017 Gaebel W, Zielasek J, Reed GM. Mental and behavioural disorders in the ICD-11: concepts, methodologies, and current status. Psychiatria Polska. 51: 169-195. PMID 28581530 DOI: 10.12740/PP/69660  0.84
2016 Pincus HA, Spaeth-Rublee B, Sara G, Goldner EM, Prince PN, Ramanuj P, Gaebel W, Zielasek J, Großimlinghaus I, Wrigley M, van Weeghel J, Smith M, Ruud T, Mitchell JR, Patton L. A review of mental health recovery programs in selected industrialized countries. International Journal of Mental Health Systems. 10: 73. PMID 27956939 DOI: 10.1186/s13033-016-0104-4  0.84
2016 Cordes J, Bechdolf A, Engelke C, Kahl KG, Balijepalli C, Lösch C, Klosterkötter J, Wagner M, Maier W, Heinz A, de Millas W, Gaebel W, Winterer G, Janssen B, Schmidt-Kraepelin C, et al. Prevalence of metabolic syndrome in female and male patients at risk of psychosis. Schizophrenia Research. PMID 27751654 DOI: 10.1016/j.schres.2016.09.012  0.84
2016 Morris R, Oertel W, Gaebel W, Goodwin GM, Little A, Montellano P, Westphal M, Nutt DJ, Di Luca M. Consensus Statement on European Brain Research The need to expand Brain Research* in Europe - 2015. The European Journal of Neuroscience. PMID 26990697 DOI: 10.1111/ejn.13236  0.84
2016 Brouwers EP, Mathijssen J, Van Bortel T, Knifton L, Wahlbeck K, Van Audenhove C, Kadri N, Chang Ch, Goud BR, Ballester D, Tófoli LF, Bello R, Jorge-Monteiro MF, Zäske H, Milaćić I, et al. Discrimination in the workplace, reported by people with major depressive disorder: a cross-sectional study in 35 countries. Bmj Open. 6: e009961. PMID 26908523 DOI: 10.1136/bmjopen-2015-009961  0.84
2016 Gaebel W. The EPA guidance document series. European Archives of Psychiatry and Clinical Neuroscience. 266: 87-8. PMID 26883037 DOI: 10.1007/s00406-016-0680-y  0.84
2016 Gaebel W, Großimlinghaus I, Kerst A, Cohen Y, Hinsche-Böckenholt A, Johnson B, Mucic D, Petrea I, Rössler W, Thornicroft G, Zielasek J. European Psychiatric Association (EPA) guidance on the quality of eMental health interventions in the treatment of psychotic disorders. European Archives of Psychiatry and Clinical Neuroscience. PMID 26874958 DOI: 10.1007/s00406-016-0677-6  0.84
2016 Keeley JW, Reed GM, Roberts MC, Evans SC, Medina-Mora ME, Robles R, Rebello T, Sharan P, Gureje O, First MB, Andrews HF, Ayuso-Mateos JL, Gaebel W, Zielasek J, Saxena S. Developing a science of clinical utility in diagnostic classification systems field study strategies for ICD-11 mental and behavioral disorders. The American Psychologist. 71: 3-16. PMID 26766762 DOI: 10.1037/a0039972  0.84
2016 Möller-Leimkühler AM, Möller HJ, Maier W, Gaebel W, Falkai P. EPA guidance on improving the image of psychiatry European Archives of Psychiatry and Clinical Neuroscience. 266: 139-154. DOI: 10.1007/s00406-016-0678-5  0.84
2016 Gaebel W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Möller HJ, Wölwer W. Concept and results of the German Research Network on Schizophrenia | Konzept und Ergebnisse des Kompetenznetzes Schizophrenie Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 59: 412-419. DOI: 10.1007/s00103-016-2311-1  0.84
2015 Zielasek J, Gaebel W. Mental health law in Germany. Bjpsych International. 12: 14-16. PMID 29093837  0.84
2015 Stamm TJ, Rampp C, Wiethoff K, Stingl J, Mössner R, O Malley G, Ricken R, Seemüller F, Keck M, Fisher R, Gaebel W, Maier W, Möller HJ, Bauer M, Adli M. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression. Journal of Psychopharmacology (Oxford, England). PMID 26645208 DOI: 10.1177/0269881115620459  0.84
2015 Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, de Millas W, Maier W, Ruhrmann S, Falkai P, Sauer H, Schmitt A, Riedel M, Klingberg S, Möller HJ. Predictors for symptom re-exacerbation after targeted stepwise drug discontinuation in first-episode schizophrenia: Results of the first-episode study within the German research network on schizophrenia. Schizophrenia Research. PMID 26607102 DOI: 10.1016/j.schres.2015.10.024  0.84
2015 Hasan A, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, et al. Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial. Schizophrenia Bulletin. PMID 26433217 DOI: 10.1093/schbul/sbv142  0.84
2015 Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, ... ... Gaebel W, et al. Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. Behavior Genetics. PMID 26392368 DOI: 10.1007/s10519-015-9737-3  0.84
2015 Reed GM, Rebello TJ, Pike KM, Medina-Mora ME, Gureje O, Zhao M, Dai Y, Roberts MC, Maruta T, Matsumoto C, Krasnov VN, Kulygina M, Lovell AM, Stona AC, Sharan P, ... ... Gaebel W, et al. WHO's Global Clinical Practice Network for mental health. The Lancet. Psychiatry. 2: 379-80. PMID 26360271 DOI: 10.1016/S2215-0366(15)00183-2  0.84
2015 Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, Busch MA, Hapke U, Maske U, Seiffert I, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU. Twelve-months prevalence of mental disorders in the German Health Interview and Examination Survey for Adults - Mental Health Module (DEGS1-MH): a methodological addendum and correction. International Journal of Methods in Psychiatric Research. PMID 26184561 DOI: 10.1002/mpr.1479  0.84
2015 Schennach R, Möller HJ, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, et al. Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods. International Journal of Methods in Psychiatric Research. PMID 26178421 DOI: 10.1002/mpr.1476  0.84
2015 Mack S, Jacobi F, Beesdo-Baum K, Gerschler A, Strehle J, Höfler M, Busch MA, Maske U, Hapke U, Gaebel W, Zielasek J, Maier W, Wittchen HU. Functional disability and quality of life decrements in mental disorders: Results from the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). European Psychiatry : the Journal of the Association of European Psychiatrists. PMID 26169476 DOI: 10.1016/j.eurpsy.2015.06.003  0.84
2015 Gaebel W, Zielasek J. Schizophrenia in 2020: Trends in diagnosis and therapy. Psychiatry and Clinical Neurosciences. 69: 661-73. PMID 26011091 DOI: 10.1111/pcn.12322  0.84
2015 Gaebel W, Zielasek J. Focus on psychosis. Dialogues in Clinical Neuroscience. 17: 9-18. PMID 25987859  0.84
2015 Gaebel W, Großimlinghaus I, Heun R, Janssen B, Johnson B, Kurimay T, Montellano P, Muijen M, Munk-Jorgensen P, Rössler W, Ruggeri M, Thornicroft G, Zielasek J. European Psychiatric Association (EPA) guidance on quality assurance in mental healthcare. European Psychiatry : the Journal of the Association of European Psychiatrists. 30: 360-87. PMID 25725593 DOI: 10.1016/j.eurpsy.2015.01.011  0.84
2015 Lloyd CE, Sartorius N, Cimino LC, Alvarez A, Guinzbourg de Braude M, Rabbani G, Uddin Ahmed H, Papelbaum M, Regina de Freitas S, Ji L, Yu X, Gaebel W, Müssig K, Chaturvedi SK, Srikanta SS, et al. The INTERPRET-DD study of diabetes and depression: a protocol. Diabetic Medicine : a Journal of the British Diabetic Association. 32: 925-34. PMID 25659409 DOI: 10.1111/dme.12719  0.84
2015 Gaebel W, Zielasek J. Homeless and mentally ill - a mental healthcare challenge for Europe Acta Psychiatrica Scandinavica. 131: 236-238. PMID 25645234 DOI: 10.1111/acps.12394  0.84
2015 Wobrock T, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, et al. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biological Psychiatry. 77: 979-88. PMID 25582269 DOI: 10.1016/j.biopsych.2014.10.009  0.84
2015 Schennach R, Riedel M, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, et al. What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder? European Psychiatry : the Journal of the Association of European Psychiatrists. 30: 43-50. PMID 25541347 DOI: 10.1016/j.eurpsy.2014.11.001  0.84
2015 Gaebel W, Zielasek J. Overcoming stigmatizing attitudes towards psychiatrists and psychiatry Acta Psychiatrica Scandinavica. 131: 5-7. PMID 25495017 DOI: 10.1111/acps.12362  0.84
2015 Schennach R, Riedel M, Obermeier M, Spellmann I, Musil R, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, et al. What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial. European Archives of Psychiatry and Clinical Neuroscience. 265: 107-16. PMID 25261210 DOI: 10.1007/s00406-014-0528-2  0.84
2015 Gaebel W, Zäske H, Zielasek J, Cleveland HR, Samjeske K, Stuart H, Arboleda-Florez J, Akiyama T, Baumann AE, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A, Fidalgo TM, et al. Stigmatization of psychiatrists and general practitioners: results of an international survey. European Archives of Psychiatry and Clinical Neuroscience. 265: 189-97. PMID 25190351 DOI: 10.1007/s00406-014-0530-8  0.84
2015 Lanfredi M, Zoppei S, Ferrari C, Bonetto C, Van Bortel T, Thornicroft G, Knifton L, Quinn N, Rossi G, Lasalvia A. Self-stigma as a mediator between social capital and empowerment among people with major depressive disorder in Europe: the ASPEN study. European Psychiatry : the Journal of the Association of European Psychiatrists. 30: 58-64. PMID 25169444 DOI: 10.1016/j.eurpsy.2014.06.002  0.84
2015 Juraeva D, Treutlein J, Scholz H, Frank J, Degenhardt F, Cichon S, Ridinger M, Mattheisen M, Witt SH, Lang M, Sommer WH, Hoffmann P, Herms S, Wodarz N, Soyka M, ... ... Gaebel W, et al. XRCC5 as a risk gene for alcohol dependence: evidence from a genome-wide gene-set-based analysis and follow-up studies in Drosophila and humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 361-71. PMID 25035082 DOI: 10.1038/npp.2014.178  0.84
2015 Bhugra D, Sartorius N, Fiorillo A, Evans-Lacko S, Ventriglio A, Hermans MHM, Vallon P, Dales J, Racetovic G, Samochowiec J, Roca Bennemar M, Becker T, Kurimay T, Gaebel W. EPA guidance on how to improve the image of psychiatry and of the psychiatrist European Psychiatry. 30: 423-430. DOI: 10.1016/j.eurpsy.2015.02.003  0.84
2015 Bhugra D, Ventriglio A, Kuzman MR, Ikkos G, Hermans MHM, Falkai P, Fiorillo A, Musalek M, Hoschl C, Dales J, Beezhold J, Rössler W, Racetovic G, Gaebel W. EPA guidance on the role and responsibilities of psychiatrists European Psychiatry. 30: 417-422. DOI: 10.1016/j.eurpsy.2015.02.002  0.84
2015 Heun R, Gaebel W. The relevance of EPA guidance papers in the framework of the European Psychiatric Association European Psychiatry. 30: 357-359. DOI: 10.1016/j.eurpsy.2015.02.001  0.84
2015 Großimlinghaus I, Falkai P, Gaebel W, Hasan A, Jänner M, Janssen B, Reich-Erkelenz D, Grüber L, Böttcher V, Wobrock T, Zielasek J. Assessment of quality indicators with routine data: Presentation of a feasibility test in ten specialist clinics for psychiatry and psychotherapy | Erhebung von Qualitätsindikatoren anhand von Routinedaten: Darstellung eines Machbarkeitstests in 10 Fachkliniken für Psychiatrie und Psychotherapie Nervenarzt. 86: 1393-1399. DOI: 10.1007/s00115-015-4357-y  0.84
2015 Zäske H, Degner D, Jockers-Scherübl M, Klingberg S, Klosterkötter J, Maier W, Möller HJ, Sauer H, Schmitt A, Gaebel W. Experiences of stigma and discrimination in patients with first-episode schizophrenia | Erleben von Stigma und Diskriminierung bei ersterkrankten Schizophreniepatienten Nervenarzt. DOI: 10.1007/s00115-015-4340-7  0.84
2015 Zielasek J, Gaebel W. Brief reactive psychoses Troublesome Disguises: Managing Challenging Disorders in Psychiatry: Second Edition. 27-43. DOI: 10.1002/9781118799574.ch3  0.84
2015 Gaebel W, Großimlinghaus I, Zielasek J. The EPA guidance project: Guidance for mental healthcare in Europe Psychiatrie. 12: 5-11.  0.84
2015 Galushko L, Graf O, Gaebel W, Zielasek J. A systematic review of cognitive and neurobiologic factors associated with specific phobias Psychiatrie. 12: 192-200.  0.84
2015 Hasan A, Wobrock T, Großimlinghaus I, Zielasek J, Janssen B, Reich-Erkelenz D, Kopp I, Gaebel W, Falkai P. Update of the DGPPN S3-guidelines for the treatment of schizophrenia: Current status | Die Aktualisierung der DGPPN S3-Leitlinie Schizophrenie - Aktueller Stand Psychiatrie. 12: 19-27.  0.84
2014 Zäske H, Freimüller L, Wölwer W, Gaebel W. Anti-stigma competence for mental health professionals: results of a pilot study of a further education programme for people working in psychiatric and psychosocial settings | Antistigma-Kompetenz in der psychiatrischen Versorgung: Ergebnisse der Pilotierung einer berufsgruppenübergreifenden Weiterbildung Fortschritte Der Neurologie-Psychiatrie. 82: 586-592. PMID 25299630 DOI: 10.1055/s-0034-1385130  0.84
2014 von Wilmsdorff M, Bouvier ML, Henning U, Schmitt A, Schneider-Axmann T, Gaebel W. Sex-dependent metabolic alterations of rat liver after 12-week exposition to haloperidol or clozapine. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et MéTabolisme. 46: 782-8. PMID 25105542 DOI: 10.1055/s-0034-1384605  0.84
2014 Luckhaus C, Kampka N, Frommann N, Dönisch-Seidel U, Gaebel W, Janssen B. Pilot study on a modular outpatient treatment programme following public order placements because of endangerment in patients with psychotic disorders | Pilot-anwendung eines modularen ambulanten therapieprogramms im anschluss an PsychKG-unterbringungen wegen fremdgefährdung bei patienten mit psychose-erkrankungen Fortschritte Der Neurologie Psychiatrie. 82: 464-470. PMID 25105433 DOI: 10.1055/s-0034-1366586  0.84
2014 Kowitz S, Zielasek J, Gaebel W. Mental healthcare in Germany - Current situation and perspectives | Die Versorgungssituation bei psychischen Störungen in Deutschland: Aktueller Stand und Perspektiven Deutsche Medizinische Wochenschrift. 139: 1249-1252. PMID 24866962 DOI: 10.1055/s-0034-1370039  0.84
2014 Wölwer W, Lowe A, Brinkmeyer J, Streit M, Habakuck M, Agelink MW, Mobascher A, Gaebel W, Cordes J. Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia. Brain Stimulation. 7: 559-63. PMID 24857264 DOI: 10.1016/j.brs.2014.04.011  0.84
2014 Gaebel W. In reply. Deutsches äRzteblatt International. 111: 271-2. PMID 24776614 DOI: 10.3238/arztebl.2014.0271c  0.84
2014 Jacobi F, Höfler M, Siegert J, Mack S, Gerschler A, Scholl L, Busch MA, Hapke U, Maske U, Seiffert I, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). International Journal of Methods in Psychiatric Research. 23: 304-19. PMID 24729411 DOI: 10.1002/mpr.1439  0.84
2014 Gaebel W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Wölwer W. 12 years of competence network schizophrenia: Results and perspectives | 12 Jahre Kompetenznetz Schizophrenie: Ergebnisse und Perspektiven Fortschritte Der Neurologie Psychiatrie. 82: 191-202. PMID 24710675 DOI: 10.1055/s-0034-1366193  0.84
2014 Mack S, Jacobi F, Gerschler A, Strehle J, Höfler M, Busch MA, Maske UE, Hapke U, Seiffert I, Gaebel W, Zielasek J, Maier W, Wittchen HU. Self-reported utilization of mental health services in the adult German population--evidence for unmet needs? Results of the DEGS1-Mental Health Module (DEGS1-MH). International Journal of Methods in Psychiatric Research. 23: 289-303. PMID 24687693 DOI: 10.1002/mpr.1438  0.84
2014 Kommescher M, Wagner M, Pützfeld V, Berning J, Janssen B, Decker P, Bottlender R, Möller HJ, Gaebel W, Maier W, Klosterkötter J, Bechdolf A. Coping as a predictor of treatment outcome in people at clinical high risk of psychosis. Early Intervention in Psychiatry. PMID 24612629 DOI: 10.1111/eip.12130  0.84
2014 Seemüller F, Meier S, Obermeier M, Musil R, Bauer M, Adli M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Riedel M, et al. Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors. European Archives of Psychiatry and Clinical Neuroscience. 264: 567-75. PMID 24590257 DOI: 10.1007/s00406-014-0495-7  0.84
2014 Zink M, Schirmbeck F, Rausch F, Eifler S, Elkin H, Solojenkina X, Englisch S, Wagner M, Maier W, Lautenschlager M, Heinz A, Gudlowski Y, Janssen B, Gaebel W, Michel TM, et al. Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function. Acta Psychiatrica Scandinavica. 130: 214-26. PMID 24571191 DOI: 10.1111/acps.12258  0.84
2014 Gaebel W, Muijen M, Baumann AE, Bhugra D, Wasserman D, van der Gaag RJ, Heun R, Zielasek J. EPA guidance on building trust in mental health services. European Psychiatry : the Journal of the Association of European Psychiatrists. 29: 83-100. PMID 24506936 DOI: 10.1016/j.eurpsy.2014.01.001  0.84
2014 Mayer S, van der Gaag RJ, Dom G, Wassermann D, Gaebel W, Falkai P, Schüle C. European Psychiatric Association (EPA) guidance on post-graduate psychiatric training in Europe. European Psychiatry : the Journal of the Association of European Psychiatrists. 29: 101-6. PMID 24503245 DOI: 10.1016/j.eurpsy.2014.01.002  0.84
2014 Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, Busch MA, Maske U, Hapke U, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU. [Mental disorders in the general population : Study on the health of adults in Germany and the additional module mental health (DEGS1-MH)]. Der Nervenarzt. 85: 77-87. PMID 24441882 DOI: 10.1007/s00115-013-3961-y  0.84
2014 Malaspina D, Walsh-Messinger J, Gaebel W, Smith LM, Gorun A, Prudent V, Antonius D, Trémeau F. Negative symptoms, past and present: a historical perspective and moving to DSM-5. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 710-24. PMID 24314851 DOI: 10.1016/j.euroneuro.2013.10.018  0.84
2014 Maruta T, Volpe U, Gaebel W, Matsumoto C, Iimori M. Should schizophrenia still be named so? Schizophrenia Research. 152: 305-6. PMID 24275581 DOI: 10.1016/j.schres.2013.11.005  0.84
2014 Gaebel W, Riesbeck M. Are there clinically useful predictors and early warning signs for pending relapse? Schizophrenia Research. 152: 469-77. PMID 23978776 DOI: 10.1016/j.schres.2013.08.003  0.84
2014 Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Heuser I, Maier W, Klosterkötter J, Falkai P, Schlösser R, Schmitt A, Riedel M, Klingberg S, Köpcke W, et al. Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia. Schizophrenia Research. 152: 478-86. PMID 23643327 DOI: 10.1016/j.schres.2013.04.012  0.84
2014 Cordes J, Thünker J, Regenbrecht G, Zielasek J, Correll CU, Schmidt-Kraepelin C, Lange-Asschenfeldt C, Agelink MW, Kahl KG, Gaebel W, Klimke A, Hauner H. Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 229-41. PMID 21745127 DOI: 10.3109/15622975.2011.592546  0.84
2014 Gaebel W, Falkai P. Psychiatry in europe | Psychiatrie in europa Psychiatrie. 11: 3-4.  0.84
2014 Gaebel W, Falkai P. The european psychiatric association: Mission, structure and perspectives | Die European psychiatric association - mission, struktur und perspektiven Psychiatrie. 11: 5-9.  0.84
2014 Gaebel W, Falkai P, Sartorius N, Zielasek J. 10 years of Die Psychiatrie | 10 Jahre die psychiatrie Psychiatrie. 11: 220-221.  0.84
2013 Holzinger A, Maier W, Gaebel W, Lindemeier A. [In Process Citation]. Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft ÖSterreichischer NervenäRzte Und Psychiater. 27: 217-9. PMID 24352851 DOI: 10.1007/s40211-013-0095-1  0.84
2013 Gaebel W, Kowitz S, Fritze J, Zielasek J. Use of health care services by people with mental illness: secondary data from three statutory health insurers and the German Statutory Pension Insurance Scheme. Deutsches äRzteblatt International. 110: 799-808. PMID 24314623 DOI: 10.3238/arztebl.2013.0799  0.84
2013 Hasan A, Wobrock T, Gaebel W, Janssen B, Zielasek J, Falkai P. National and international schizophrenia guidelines: Update 2013 regarding recommendations about antipsychotic pharmacotherapy | Nationale und internationale Leitlinien zur Schizophrenie: Update 2013 zum Stand der Empfehlungen zur antipsychotischen Medikation Nervenarzt. 84: 1359-1368. PMID 24077969 DOI: 10.1007/s00115-013-3913-6  0.84
2013 Tandon R, Heckers S, Bustillo J, Barch DM, Gaebel W, Gur RE, Malaspina D, Owen MJ, Schultz S, Tsuang M, van Os J, Carpenter W. Catatonia in DSM-5. Schizophrenia Research. 150: 26-30. PMID 23806583 DOI: 10.1016/j.schres.2013.04.034  0.84
2013 Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, Malaspina D, Owen MJ, Schultz S, Tsuang M, Van Os J, Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizophrenia Research. 150: 3-10. PMID 23800613 DOI: 10.1016/j.schres.2013.05.028  0.84
2013 Jacobi F, Mack S, Gerschler A, Scholl L, Höfler M, Siegert J, Bürkner A, Preiss S, Spitzer K, Busch M, Hapke U, Gaebel W, Maier W, Wagner M, Zielasek J, et al. The design and methods of the mental health module in the German Health Interview and Examination Survey for Adults (DEGS1-MH). International Journal of Methods in Psychiatric Research. 22: 83-99. PMID 23788523 DOI: 10.1002/mpr.1387  0.84
2013 Tsuang MT, Van Os J, Tandon R, Barch DM, Bustillo J, Gaebel W, Gur RE, Heckers S, Malaspina D, Owen MJ, Schultz S, Carpenter W. Attenuated psychosis syndrome in DSM-5. Schizophrenia Research. 150: 31-5. PMID 23773295 DOI: 10.1016/j.schres.2013.05.004  0.84
2013 Malaspina D, Owen MJ, Heckers S, Tandon R, Bustillo J, Schultz S, Barch DM, Gaebel W, Gur RE, Tsuang M, Van Os J, Carpenter W. Schizoaffective Disorder in the DSM-5. Schizophrenia Research. 150: 21-5. PMID 23707642 DOI: 10.1016/j.schres.2013.04.026  0.84
2013 Heckers S, Barch DM, Bustillo J, Gaebel W, Gur R, Malaspina D, Owen MJ, Schultz S, Tandon R, Tsuang M, Van Os J, Carpenter W. Structure of the psychotic disorders classification in DSM-5. Schizophrenia Research. 150: 11-4. PMID 23707641 DOI: 10.1016/j.schres.2013.04.039  0.84
2013 Barch DM, Bustillo J, Gaebel W, Gur R, Heckers S, Malaspina D, Owen MJ, Schultz S, Tandon R, Tsuang M, Van Os J, Carpenter W. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5. Schizophrenia Research. 150: 15-20. PMID 23706415 DOI: 10.1016/j.schres.2013.04.027  0.84
2013 Wölwer W, Toeller V, Klingberg S, Gaebel W. Specialised treatment in first episode schizophrenia: Concepts and results | Spezialisierte Behandlungsangebote für erstmals schizophren Erkrankte: Konzepte und Ergebnisse Fortschritte Der Neurologie Psychiatrie. 81: 276-283. PMID 23695792 DOI: 10.1055/s-0032-1330507  0.84
2013 Gaebel W, Zielasek J, Cleveland HR. Psychotic disorders in ICD-11. Asian Journal of Psychiatry. 6: 263-5. PMID 23642991 DOI: 10.1016/j.ajp.2013.04.002  0.84
2013 Anderson-Schmidt H, Adler L, Aly C, Anghelescu IG, Bauer M, Baumgärtner J, Becker J, Bianco R, Becker T, Bitter C, Bönsch D, Buckow K, Budde M, Bührig M, Deckert J, ... ... Gaebel W, et al. The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients. European Archives of Psychiatry and Clinical Neuroscience. 263: 695-701. PMID 23545941 DOI: 10.1007/s00406-013-0401-8  0.84
2013 Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, ... Gaebel W, et al. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research. 147: 132-9. PMID 23537477 DOI: 10.1016/j.schres.2013.03.001  0.84
2013 Großimlinghaus I, Falkai P, Gaebel W, Janssen B, Reich-Erkelenz D, Wobrock T, Zielasek J. Developmental process of DGPPN quality indicators | Entwicklungsprozess der DGPPN-Qualitätsindikatoren Nervenarzt. 84: 350-365. PMID 23494246 DOI: 10.1007/s00115-012-3705-4  0.84
2013 Cleveland HR, Baumann A, Zäske H, Jänner M, Icks A, Gaebel W. Association of lay beliefs about causes of depression with social distance. Acta Psychiatrica Scandinavica. 128: 397-405. PMID 23405881 DOI: 10.1111/acps.12088  0.84
2013 Fisher CE, Spaeth-Rublee B, Alan Pincus H. Developing mental health-care quality indicators: toward a common framework. International Journal For Quality in Health Care : Journal of the International Society For Quality in Health Care / Isqua. 25: 75-80. PMID 23175534 DOI: 10.1093/intqhc/mzs074  0.84
2013 Lasalvia A, Zoppei S, Van Bortel T, Bonetto C, Cristofalo D, Wahlbeck K, Bacle SV, Van Audenhove C, Van Weeghel J, Reneses B, Germanavicius A, Economou M, Lanfredi M, Ando S, Sartorius N, ... ... Gaebel W, et al. Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: A cross-sectional survey The Lancet. 381: 55-62. PMID 23083627 DOI: 10.1016/S0140-6736(12)61379-8  0.84
2013 Musil R, Zill P, Seemüller F, Bondy B, Meyer S, Spellmann I, Bender W, Adli M, Heuser I, Fisher R, Gaebel W, Maier W, Rietschel M, Rujescu D, Schennach R, et al. Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 663-74. PMID 23063133 DOI: 10.1016/j.euroneuro.2012.08.009  0.84
2013 Musil R, Zill P, Seemüller F, Bondy B, Obermeier M, Spellmann I, Bender W, Adli M, Heuser I, Zeiler J, Gaebel W, Maier W, Rietschel M, Rujescu D, Schennach R, et al. No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression. European Archives of Psychiatry and Clinical Neuroscience. 263: 405-12. PMID 22965830 DOI: 10.1007/s00406-012-0364-1  0.84
2013 Schennach R, Riesbeck M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Jäger M, Wölwer W, Gaebel W, et al. Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients? Acta Psychiatrica Scandinavica. 127: 474-481. PMID 22957829 DOI: 10.1111/acps.12006  0.84
2013 von Wilmsdorff M, Bouvier ML, Henning U, Schmitt A, Schneider-Axmann T, Gaebel W. The sex-dependent impact of chronic clozapine and haloperidol treatment on characteristics of the metabolic syndrome in a rat model. Pharmacopsychiatry. 46: 1-9. PMID 22915487 DOI: 10.1055/s-0032-1321907  0.84
2013 Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/j.euroneuro.2012.04.019  0.84
2013 Großimlinghaus I, Falkai P, Gaebel W, Janssen B, Reich-Erkelenz D, Wobrock T, Zielasek J. Reply | Replik Nervenarzt. 84: 1383-1384. DOI: 10.1007/s00115-013-3883-8  0.84
2013 Wannagat W, Zielasek J, Gaebel W. Therapy of post-stroke depression - A systematic review Psychiatrie. 10: 108-129.  0.84
2013 Gaebel W, Zielasek J, Falkai P. Mental health and the workplace | Psychische gesundheit und die arbeitswelt Psychiatrie. 10: 59-60.  0.84
2013 Gaebel W, Sartorius N, Zielasek J. Revision of the classification systems: DSM-5 and ICD-11 | Revision der Klassifikations systeme: DSM-5 und ICD-11 Psychiatrie. 10: 3-4.  0.84
2012 Gaebel W, Zielasek J, Cleveland HR. Classifying psychosis--challenges and opportunities. International Review of Psychiatry (Abingdon, England). 24: 538-48. PMID 23244609 DOI: 10.3109/09540261.2012.737313  0.84
2012 Gaebel W. Status of psychotic disorders in ICD-11. Schizophrenia Bulletin. 38: 895-8. PMID 22987845 DOI: 10.1093/schbul/sbs104  0.84
2012 Gaebel W, Zielasek J. Psychiatry in Germany 2012. International Review of Psychiatry (Abingdon, England). 24: 371-8. PMID 22950779 DOI: 10.3109/09540261.2012.698983  0.84
2012 Bhugra D, Gaebel W, Zielasek J. State of psychiatry in Europe. International Review of Psychiatry (Abingdon, England). 24: 273. PMID 22950763 DOI: 10.3109/09540261.2012.697266  0.84
2012 Gaebel W, Kowitz S, Zielasek J. The DGPPN research project on mental healthcare utilization in Germany: inpatient and outpatient treatment of persons with depression by different disciplines. European Archives of Psychiatry and Clinical Neuroscience. 262: S51-5. PMID 22940745 DOI: 10.1007/s00406-012-0363-2  0.84
2012 Seemüller F, Schennach R, Mayr A, Musil R, Jäger M, Maier W, Klingenberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Ohmann C, Lewitzka U, ... Gaebel W, et al. Akathisia and suicidal ideation in first-episode schizophrenia. Journal of Clinical Psychopharmacology. 32: 694-8. PMID 22926606 DOI: 10.1097/JCP.0b013e3182677958  0.84
2012 Wölwer W, Stroth S, Brinkmeyer J, Gaebel W. Electrophysiological correlates of planning and monitoring in first episode schizophrenia. Psychiatry Research. 203: 83-8. PMID 22901626 DOI: 10.1016/j.pscychresns.2011.11.009  0.84
2012 Schennach R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Psychopathology. 45: 276-85. PMID 22796716 DOI: 10.1159/000336729  0.84
2012 Weinmann S, Gühne U, Kösters M, Gaebel W, Becker T. ManagementTeam-based community psychiatry. Importance of context factors and transferability of evidence from studies | Teambasierte gemeindepsychiatrie: Bedeutung von kontextfaktoren und Übertragbarkeit der studienevidenz Nervenarzt. 83: 825-831. PMID 22688090 DOI: 10.1007/s00115-011-3468-3  0.84
2012 Schennach R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Response trajectories in "real-world" naturalistically treated schizophrenia patients. Schizophrenia Research. 139: 218-24. PMID 22658528 DOI: 10.1016/j.schres.2012.05.004  0.84
2012 Schuhmacher A, Becker T, Rujescu D, Quednow BB, Lennertz L, Wagner M, Benninghoff J, Rietschel M, Häfner H, Franke P, Wölwer W, Gaebel W, Maier W, Mössner R. Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics. Journal of Psychiatric Research. 46: 1073-80. PMID 22655589 DOI: 10.1016/j.jpsychires.2012.04.021  0.84
2012 Schennach R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder European Psychiatry. 27: 625-633. PMID 22542652 DOI: 10.1016/j.eurpsy.2012.01.001  0.84
2012 Gaebel W, Zielasek J. From genes to mental representations: a comment to "why schizophrenia genetics needs epigenetics". Psychiatria Danubina. 24: 28-30. PMID 22447082  0.84
2012 Spellmann I, Riedel M, Schennach R, Seemüller F, Obermeier M, Musil R, Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, et al. One-year functional outcomes of naturalistically treated patients with schizophrenia. Psychiatry Research. 198: 378-85. PMID 22421065 DOI: 10.1016/j.psychres.2011.12.047  0.84
2012 Gaebel W, Becker T, Janssen B, Munk-Jorgensen P, Musalek M, Rössler W, Sommerlad K, Tansella M, Thornicroft G, Zielasek J. EPA guidance on the quality of mental health services European Psychiatry. 27: 87-113. PMID 22264656 DOI: 10.1016/j.eurpsy.2011.12.001  0.84
2012 Schennach R, Obermeier M, Meyer S, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatric Services (Washington, D.C.). 63: 87-90. PMID 22227766 DOI: 10.1176/appi.ps.201100084  0.84
2012 Gaebel W, Riesbeck M. Only 10% of people with schizophrenia show sustained improvements over 3 years. Evidence-Based Mental Health. 15: 15. PMID 22184639 DOI: 10.1136/ebmental-2011-100330  0.84
2012 Gaebel W, Möller HJ. European guidance-a project of the European Psychiatric Association European Psychiatry. 27: 65-67. PMID 22137774 DOI: 10.1016/j.eurpsy.2011.08.003  0.84
2012 Lennertz L, Quednow BB, Schuhmacher A, Petrovsky N, Frommann I, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Höfels S, Pukrop R, Klosterkötter J, Franke PE, Wölwer W, Gaebel W, Häfner H, et al. The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1205-15. PMID 22078257 DOI: 10.1017/S1461145711001623  0.84
2012 Bechdolf A, Wagner M, Ruhrmann S, Harrigan S, Putzfeld V, Pukrop R, Brockhaus-Dumke A, Berning J, Janssen B, Decker P, Bottlender R, Maurer K, Möller HJ, Gaebel W, Häfner H, et al. Preventing progression to first-episode psychosis in early initial prodromal states. The British Journal of Psychiatry : the Journal of Mental Science. 200: 22-9. PMID 22075649 DOI: 10.1192/bjp.bp.109.066357  0.84
2012 Schennach R, Riedel M, Obermeier M, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial. The Psychiatric Quarterly. 83: 187-207. PMID 22038270 DOI: 10.1007/s11126-011-9193-z  0.84
2012 Frank J, Cichon S, Treutlein J, Ridinger M, Mattheisen M, Hoffmann P, Herms S, Wodarz N, Soyka M, Zill P, Maier W, Mössner R, Gaebel W, Dahmen N, Scherbaum N, et al. Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addiction Biology. 17: 171-80. PMID 22004471 DOI: 10.1111/j.1369-1600.2011.00395.x  0.84
2012 Jantzen SU, Ferrea S, Langebner T, Gaebel W, Griese M, Arendt G, Dihné M. Late-stage neurosyphilis presenting with severe neuropsychiatric deficits: diagnosis, therapy, and course of three patients. Journal of Neurology. 259: 720-8. PMID 21964751 DOI: 10.1007/s00415-011-6252-1  0.84
2012 Lennertz L, Wagner M, Wölwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Alexander M, Franke PE, Pukrop R, Ruhrmann S, Bechdolf A, Gaebel W, et al. A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. European Archives of Psychiatry and Clinical Neuroscience. 262: 117-24. PMID 21901269 DOI: 10.1007/s00406-011-0233-3  0.84
2012 Riedel M, Mayr A, Seemüller F, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Schennach-Wolff R. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 13: 30-8. PMID 21568628 DOI: 10.3109/15622975.2011.552633  0.84
2012 Wölwer W, Brinkmeyer J, Stroth S, Streit M, Bechdolf A, Ruhrmann S, Wagner M, Gaebel W. Neurophysiological correlates of impaired facial affect recognition in individuals at risk for schizophrenia. Schizophrenia Bulletin. 38: 1021-9. PMID 21402721 DOI: 10.1093/schbul/sbr013  0.84
2012 Seemüller F, Riedel M, Obermeier M, Schennach-Wolff R, Spellmann I, Meyer S, Bauer M, Adli M, Kronmüller K, Ising M, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, ... Gaebel W, et al. The validity of self-rated psychotic symptoms in depressed inpatients. European Psychiatry : the Journal of the Association of European Psychiatrists. 27: 547-52. PMID 21392943 DOI: 10.1016/j.eurpsy.2011.01.004  0.84
2012 Zarafonitis S, Wagner M, Pützfeld V, Berning J, Janssen B, Decker P, Bottlender R, Möller HJ, Gaebel W, Maier W, Klosterkötter J, Bechdolf A. Psychoeducation for persons at risk of psychosis: Results of a randomized controlled study | Psychoedukation bei Personen mit erhöhtem Psychoserisiko: Ergebnisse einer randomisierten, kontrollierten Studie Psychotherapeut. 57: 326-334. DOI: 10.1007/s00278-012-0928-6  0.84
2012 Frommann N, Luckhaus C, Dönisch-Seidel U, Gaebel W, Janssen B. Schizophrenia and aggression against others: A project to prevent illness related aggressive behavior against others by optimizing treatment in general psychiatry | Schizophrenie und fremdaggression: Ein projekt zur prävention fremdaggressiven verhaltens im rahmen psychotischer störungen durch behandlungsoptimierung in der allgemeinpsychiatrie Recht Und Psychiatrie. 30: 186-190.  0.84
2012 Gaebel W, Zielasek J, Sartorius N. Comorbidity of mental and somatic disorders | Komorbidität psychischer und somatischer Erkrankungen Psychiatrie. 9: 134-135.  0.84
2012 Zielasek J, Großimlinghaus I, Janssen B, Wobrock T, Falkai P, Reich-Erkelenz D, Riesbeck M, Gaebel W. The role of quality indicators in psychiatric quality assurance and the status of the development of quality indicators | Die Rolle von Qualitätsindikatoren in der psychiatrischen Qualitätssicherung und aktueller Stand der Entwicklung von Qualitätsindikatoren Psychiatrie. 9: 46-52.  0.84
2011 Gaebel W, Riesbeck M, Wobrock T. Schizophrenia guidelines across the world: a selective review and comparison. International Review of Psychiatry (Abingdon, England). 23: 379-87. PMID 22026495 DOI: 10.3109/09540261.2011.606801  0.84
2011 Gaebel W, Zäske H, Cleveland HR, Zielasek J, Stuart H, Arboleda-Florez J, Akiyama T, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A, Sartorius N. Measuring the stigma of psychiatry and psychiatrists: development of a questionnaire. European Archives of Psychiatry and Clinical Neuroscience. 261: S119-23. PMID 21947511 DOI: 10.1007/s00406-011-0252-0  0.84
2011 Schennach-Wolff R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder. Journal of Psychiatric Research. 45: 1639-47. PMID 21862035 DOI: 10.1016/j.jpsychires.2011.07.014  0.84
2011 Gaebel W, Zielasek J. Integrative etiopathogenetic models of psychotic disorders: methods, evidence and concepts. Schizophrenia Bulletin. 37: S5-12. PMID 21860047 DOI: 10.1093/schbul/sbr078  0.84
2011 Bechdolf A, Müller H, Stützer H, Wagner M, Maier W, Lautenschlager M, Heinz A, de Millas W, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Brüne M, et al. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis. Schizophrenia Bulletin. 37: S111-21. PMID 21860040 DOI: 10.1093/schbul/sbr083  0.84
2011 Janssen B, van Brederode M, Kitzig F, Schmidt-Kraepelin C, Ohm S, Gaebel W. [Benchmarking in psychiatric acute care--a demonstration project in a hospitals network]. Zeitschrift FüR Evidenz, Fortbildung Und QualitäT Im Gesundheitswesen. 105: 371-5. PMID 21767796 DOI: 10.1016/j.zefq.2011.05.016  0.84
2011 Puschner B, Steffen S, Völker KA, Spitzer C, Gaebel W, Janssen B, Klein HE, Spiessl H, Steinert T, Grempler J, Muche R, Becker T. Needs-oriented discharge planning for high utilisers of psychiatric services: Multicentre randomised controlled trial Epidemiology and Psychiatric Sciences. 20: 181-192. PMID 21714365 DOI: 10.1017/S2045796011000278  0.84
2011 Wölwer W, Frommann N, Jänner M, Franke PE, Scherbaum N, Lieb B, Falkai P, Wobrock T, Kuhlmann T, Radermacher M, Maier W, Schütz C, Ohmann C, Burtscheidt W, Gaebel W. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial. Drug and Alcohol Dependence. 118: 417-22. PMID 21621929 DOI: 10.1016/j.drugalcdep.2011.05.001  0.84
2011 Riedel M, Möller HJ, Obermeier M, Adli M, Bauer M, Kronmüller K, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Schennach-Wolff R, Henkel V, Seemüller F. Clinical predictors of response and remission in inpatients with depressive syndromes. Journal of Affective Disorders. 133: 137-49. PMID 21555156 DOI: 10.1016/j.jad.2011.04.007  0.84
2011 Cordes J, Kahl KG, Werner C, Henning U, Regenbrecht G, Larisch R, Schmidt-Kraepelin C, Thünker J, Agelink MW, Löffler S, Hohlfeld T, Gaebel W, Klimke A. Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study. European Archives of Psychiatry and Clinical Neuroscience. 261: 567-73. PMID 21404115 DOI: 10.1007/s00406-011-0201-y  0.84
2011 Specka M, Lieb B, Kuhlmann T, Frommann N, Wobrock T, Schifano F, Gaebel W, Scherbaum N. Marked reduction of heavy drinking did not reduce nicotine use over 1 year in a clinical sample of alcohol-dependent patients Pharmacopsychiatry. 44: 120-121. PMID 21298613 DOI: 10.1055/s-0031-1271685  0.84
2011 Schennach-Wolff R, Jäger M, Mayr A, Meyer S, Kühn KU, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Schmitt A, Schlösser R, Schneider F, Gaebel W, Seemüller F, Möller HJ, et al. Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 21: 370-8. PMID 21255982 DOI: 10.1016/j.euroneuro.2010.10.003  0.84
2011 Lennertz L, Rujescu D, Wagner M, Frommann I, Schulze-Rauschenbach S, Schuhmacher A, Landsberg MW, Franke P, Möller HJ, Wölwer W, Gaebel W, Häfner H, Maier W, Mössner R. Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. Neuropsychobiology. 63: 131-6. PMID 21228604 DOI: 10.1159/000317844  0.84
2011 Umehara H, Fangerau H, Gaebel W, Kim Y, Schott H, Zielasek J. From "schizophrenia" to "disturbance of the integrity of the self". Causes and consequences of renaming schizophrenia in Japan in 2002 | Von der "schizophrenie" zur "störung der einheit des selbst": Ursachen und folgen der umbenennung der schizophrenie in Japan im jahre 2002 Nervenarzt. 82: 1160-1168. PMID 21206996 DOI: 10.1007/s00115-010-3208-0  0.84
2011 Bodatsch M, Ruhrmann S, Wagner M, Müller R, Schultze-Lutter F, Frommann I, Brinkmeyer J, Gaebel W, Maier W, Klosterkötter J, Brockhaus-Dumke A. Prediction of psychosis by mismatch negativity. Biological Psychiatry. 69: 959-66. PMID 21167475 DOI: 10.1016/j.biopsych.2010.09.057  0.84
2011 Seitz RJ, Gaebel W, Zielasek J. Modular networks involving the medial frontal cortex: towards the development of neuropsychiatry. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 249-59. PMID 21155633 DOI: 10.3109/15622975.2010.541284  0.84
2011 Schennach-Wolff R, Obermeier M, Seemüller F, Jäger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale Acta Psychiatrica Scandinavica. 123: 228-238. PMID 21029053 DOI: 10.1111/j.1600-0447.2010.01608.x  0.84
2011 Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Riedel M, et al. Relationship between baseline severity of depression and antidepressant treatment outcome. Pharmacopsychiatry. 44: 27-32. PMID 20981642 DOI: 10.1055/s-0030-1267177  0.84
2011 Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Lemke M, Heuser I, Maier W, Huff W, Schmitt A, Sauer H, Riedel M, Klingberg S, Köpcke W, et al. Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia. The Journal of Clinical Psychiatry. 72: 205-18. PMID 20673559 DOI: 10.4088/JCP.09m05459yel  0.84
2011 Schennach-Wolff R, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Buchkremer G, et al. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders European Psychiatry. 26: 284-292. PMID 20435447 DOI: 10.1016/j.eurpsy.2009.11.005  0.84
2011 Frommann I, Pukrop R, Brinkmeyer J, Bechdolf A, Ruhrmann S, Berning J, Decker P, Riedel M, Möller HJ, Wölwer W, Gaebel W, Klosterkötter J, Maier W, Wagner M. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. Schizophrenia Bulletin. 37: 861-73. PMID 20053865 DOI: 10.1093/schbul/sbp155  0.84
2011 Gaebel W. Schizophrenia: Current Science and Clinical Practice Schizophrenia: Current Science and Clinical Practice. DOI: 10.1002/9780470978672  0.84
2011 Gaebel W, Zäske H. Coercive Treatment and Stigma - Is There a Link? Coercive Treatment in Psychiatry: Clinical, Legal and Ethical Aspects. 13-32. DOI: 10.1002/9780470978573.ch2  0.84
2011 Gaebel W, Zielasek J, Kowitz S. Using routine data of the German inpatient remuneration system for psychiatric/psychosomatic mental health services research | Nutzung von routinedaten für die psychiatrische und psychosomatische versorgungsforschung Psychiatrie. 8: 23-33.  0.84
2011 Gaebel W, Zielasek J. Financing model of a psychiatric-psychosomatic health care - International perspectives | Finanzierungsmodelle psychiatrisch-psychosomatischer krankenversorgung - Internationale perspektiven Psychiatrie. 8: 3-4.  0.84
2011 Sartorius N, Gaebel W, Cleveland HR, Stuart H, Akiyama T, Arboleda-Flórez J, Baumann AE, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A. WPA guidance on how to combat stigmatization of psychiatry and psychiatrists | Wytyczne WPA: Jak przeciwdzialac stygmatyzacji psychiatrii i psychiatrów Postepy Psychiatrii I Neurologii. 20: 89-104.  0.84
2011 Gaebel W, Zielasek J, Kowitz S, Fritze J. Patients with mental disorders: Often at the specialists | Patienten mit psychischen störungen: Oft am spezialisten vorbei Deutsches Arzteblatt. 108: A1476-A1478.  0.84
2011 Hyman SE, Andrews G, Ayuso-Mateos JL, Gaebel W, Goldberg DP, Gureje O, Jablensky A, Khoury B, Lovell A, Medina Mora ME, Rahimi-Movaghar A, Ritchie K, Saeed K, Sartorius N, Sharan P, et al. A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders World Psychiatry. 10: 86-92.  0.84
2010 Schennach-Wolff R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study. Journal of Clinical Psychopharmacology. 30: 726-31. PMID 21105273 DOI: 10.1097/JCP.0b013e3181faf39b  0.84
2010 von Wilmsdorff M, Bouvier ML, Henning U, Schmitt A, Gaebel W. The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats. Clinics (SãO Paulo, Brazil). 65: 885-94. PMID 21049217 DOI: 10.1590/S1807-59322010000900012  0.84
2010 Sartorius N, Gaebel W, Cleveland HR, Stuart H, Akiyama T, Arboleda-Flórez J, Baumann AE, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A. WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 9: 131-44. PMID 20975855  0.84
2010 Schennach-Wolff R, Möller HJ, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, et al. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials Pharmacopsychiatry. 43: 245-251. PMID 20927697 DOI: 10.1055/s-0030-1262788  0.84
2010 Musalek M, Larach-Walters V, Lépine JP, Millet B, Gaebel W. Psychopathology in the 21st century. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 844-51. PMID 20863172 DOI: 10.3109/15622975.2010.510207  0.84
2010 Spaeth-Rublee B, Pincus HA, Huynh PT, Brown P, Rosen A, Durbin J, Goldbloom D, Lin E, Wiebe P, Griffiths H, Gaebel W, Zielasek J, Janssen B, Sommerlad K, Brogan C, et al. Measuring quality of mental health care: A review of initiatives and programs in selected countries Canadian Journal of Psychiatry. 55: 539-548. PMID 20840801  0.84
2010 Seemüller F, Möller HJ, Obermeier M, Adli M, Bauer M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Schennach-Wolff R, Henkel V, et al. Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. The Journal of Clinical Psychiatry. 71: 1425-33. PMID 20816028 DOI: 10.4088/JCP.09m05166blu  0.84
2010 Gaebel W, Schreiner A, Bergmans P, de Arce R, Rouillon F, Cordes J, Eriksson L, Smeraldi E. Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2367-77. PMID 20686456 DOI: 10.1038/npp.2010.111  0.84
2010 Zielasek J, Freyberger HJ, Jänner M, Kapfhammer HP, Sartorius N, Stieglitz RD, Gaebel W. Assessing the opinions and experiences of German-speaking psychiatrists regarding necessary changes for the 11th revision of the mental disorders chapter of the international classification of disorders (ICD-11) European Psychiatry. 25: 437-442. PMID 20646914 DOI: 10.1016/j.eurpsy.2009.12.023  0.84
2010 Luckhaus C, Cohnen M, Flüss MO, Jänner M, Grass-Kapanke B, Teipel SJ, Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Mödder U, Wittsack HJ. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Research. 183: 44-51. PMID 20541374 DOI: 10.1016/j.pscychresns.2010.04.003  0.84
2010 Schennach-Wolff R, Seemüller FH, Mayr A, Maier W, Klingberg S, Heuser I, Klosterkötter J, Gastpar M, Häfner H, Sauer H, Schneider F, Gaebel W, Jäger M, Möller HJ, Riedel M. An early improvement threshold to predict response and remission in first-episode schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 196: 460-6. PMID 20513856 DOI: 10.1192/bjp.bp.109.069328  0.84
2010 Bermejo I, Kriston L, Schneider F, Gaebel W, Hegerl U, Berger M, Härter M. Sick leave and depression - determining factors and clinical effect in outpatient care. Psychiatry Research. 180: 68-73. PMID 20494453 DOI: 10.1016/j.psychres.2010.04.028  0.84
2010 Riedel M, Möller HJ, Obermeier M, Schennach-Wolff R, Bauer M, Adli M, Kronmüller K, Nickel T, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Seemüller F. Response and remission criteria in major depression--a validation of current practice. Journal of Psychiatric Research. 44: 1063-8. PMID 20447651 DOI: 10.1016/j.jpsychires.2010.03.006  0.84
2010 Luckhaus C, Jänner M, Cohnen M, Flüss MO, Teipel SJ, Grothe M, Hampel H, Kornhuber J, Rüther E, Peters O, Supprian T, Gaebel W, Mödder U, Wittsack HJ. A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 17: 1437-44. PMID 20443979 DOI: 10.1111/j.1468-1331.2010.03038.x  0.84
2010 Schennach-Wolff R, Jäger M, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, et al. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 729-38. PMID 20380620 DOI: 10.3109/15622971003690289  0.84
2010 Cordes J, Thünker J, Agelink MW, Arends M, Mobascher A, Wobrock T, Schneider-Axmann T, Brinkmeyer J, Mittrach M, Regenbrecht G, Wölwer W, Winterer G, Gaebel W. Effects of 10 Hz repetitive transcranial magnetic stimulation (rTMS) on clinical global impression in chronic schizophrenia. Psychiatry Research. 177: 32-6. PMID 20378181 DOI: 10.1016/j.psychres.2009.01.014  0.84
2010 Lennertz L, Wagner M, Frommann I, Schulze-Rauschenbach S, Schuhmacher A, Kühn KU, Pukrop R, Klosterkötter J, Wölwer W, Gaebel W, Rietschel M, Häfner H, Maier W, Mössner R. A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 414-20. PMID 20356718 DOI: 10.1016/j.euroneuro.2010.02.012  0.84
2010 Gaebel W, Riesbeck M, von Wilmsdorff M, Burns T, Derks EM, Kahn RS, Rössler W, Fleischhacker WW. Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 310-6. PMID 20202800 DOI: 10.1016/j.euroneuro.2010.02.001  0.84
2010 von Wilmsdorff M, Sprick U, Bouvier ML, Schulz D, Schmitt A, Gaebel W. Sex-dependent behavioral effects and morphological changes in the hippocampus after prenatal invasive interventions in rats: implications for animal models of schizophrenia. Clinics (SãO Paulo, Brazil). 65: 209-19. PMID 20186306 DOI: 10.1590/S1807-59322010000200014  0.84
2010 Jäger M, Riedel M, Obermeier M, Schennach-Wolff R, Seemüller F, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, et al. Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients Schizophrenia Research. 118: 183-188. PMID 20181461 DOI: 10.1016/j.schres.2010.02.002  0.84
2010 Gaebel W, Zielasek J, Cleveland HR. Psychiatry as a medical specialty: challenges and opportunities. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 9: 36-8. PMID 20148157  0.84
2010 Mittrach M, Thünker J, Winterer G, Agelink MW, Regenbrecht G, Arends M, Mobascher A, Kim SJ, Wölwer W, Brinkmeyer J, Gaebel W, Cordes J. The tolerability of rTMS treatment in schizophrenia with respect to cognitive function Pharmacopsychiatry. 43: 110-117. PMID 20127616 DOI: 10.1055/s-0029-1242824  0.84
2010 Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Kronmüller K, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Dichgans E, Bottländer R, et al. Outcomes of 1014 naturalistically treated inpatients with major depressive episode. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 346-55. PMID 20097046 DOI: 10.1016/j.euroneuro.2009.11.011  0.84
2010 Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Outcome of suicidal patients with schizophrenia: Results from a naturalistic study Acta Psychiatrica Scandinavica. 121: 359-370. PMID 19878135 DOI: 10.1111/j.1600-0447.2009.01484.x  0.84
2010 Janssen B, Ludwig S, Eustermann H, Menke R, Haerter M, Berger M, Adam G, Seemann U, Kissling W, Gaebel W. Improving outpatient treatment in schizophrenia: Effects of computerized guideline implementation-results of a multicenter-study within the German Research Network on Schizophrenia European Archives of Psychiatry and Clinical Neuroscience. 260: 51-57. PMID 19876665 DOI: 10.1007/s00406-009-0016-2  0.84
2010 Simons G, Ellgring JH, Beck-Dossler K, Gaebel W, Wölwer W. Facial expression in male and female schizophrenia patients. European Archives of Psychiatry and Clinical Neuroscience. 260: 267-76. PMID 19816738 DOI: 10.1007/s00406-009-0074-5  0.84
2010 Mössner R, Schuhmacher A, Wagner M, Quednow BB, Frommann I, Kühn KU, Schwab SG, Rietschel M, Falkai P, Wölwer W, Ruhrmann S, Bechdolf A, Gaebel W, Klosterkötter J, Maier W. DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis. European Archives of Psychiatry and Clinical Neuroscience. 260: 209-15. PMID 19763662 DOI: 10.1007/s00406-009-0044-y  0.84
2010 Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M. Does early improvement triggered by antidepressants predict response/ remission?- Analysis of data from a naturalistic study on a large sample of inpatients with major depression | ¿Predice la mejoría precoz inducida por los antidepresivos la respuesta/remisión? Análisis de los datos de un estudio naturalista en una muestra a gran escala de pacientes hospitalizados con depresión mayor Psiquiatria Biologica. 17: 45-53. DOI: 10.1016/j.psiq.2010.01.006  0.84
2010 Gaebel W, Wölwer W, Riesbeck M, Zielasek J. The cross-sectional and longitudinal architecture of schizophrenia: Significance for diagnosis and intervention? Advances in Schizophrenia Research 2009. 317-330. DOI: 10.1007/978-1-4419-0913-8_17  0.84
2010 Gaebel W, Zielasek J, Cleveland HR. Psychiatry as a medical specialty: Challenges and opportunities | Psychiatria jako specjalność medyczna: Wyzwania i możliwości Postepy Psychiatrii I Neurologii. 19: 107-109.  0.84
2010 Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Möller HJ, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, et al. Social disability and symptomatic outcome in schizophrenia -where are the unmet needs of schizophrenia patients? International Journal of Psychosocial Rehabilitation. 15.  0.84
2009 Wobrock T, Weinmann S, Falkai P, Gaebel W. Quality assurance in psychiatry: Quality indicators and guideline implementation European Archives of Psychiatry and Clinical Neuroscience. 259: S219-S226. PMID 19876682 DOI: 10.1007/s00406-009-0072-7  0.84
2009 Gaebel W, Zielasek J. Future classification of psychotic disorders. European Archives of Psychiatry and Clinical Neuroscience. 259: S213-8. PMID 19876681 DOI: 10.1007/s00406-009-0049-6  0.84
2009 Schmidt-Kraepelin C, Janssen B, Gaebel W. Prevention of rehospitalization in schizophrenia: results of an integrated care project in Germany. European Archives of Psychiatry and Clinical Neuroscience. 259: S205-12. PMID 19876680 DOI: 10.1007/s00406-009-0056-7  0.84
2009 Kuhn J, Gaebel W, Klosterkoetter J, Woopen C. Deep brain stimulation as a new therapeutic approach in therapy-resistant mental disorders: ethical aspects of investigational treatment. European Archives of Psychiatry and Clinical Neuroscience. 259: S135-41. PMID 19876671 DOI: 10.1007/s00406-009-0055-8  0.84
2009 Gaebel W, Zielasek J. Editorial: Psychiatry as a therapeutic discipline European Archives of Psychiatry and Clinical Neuroscience. 259: S107. PMID 19876666 DOI: 10.1007/s00406-009-0063-8  0.84
2009 Schuhmacher A, Mössner R, Quednow BB, Kühn KU, Wagner M, Cvetanovska G, Rujescu D, Zill P, Möller HJ, Rietschel M, Franke P, Wölwer W, Gaebel W, Maier W. Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia. Pharmacogenetics and Genomics. 19: 843-51. PMID 19794330 DOI: 10.1097/FPC.0b013e3283313296  0.84
2009 Gaebel W, Janssen B, Zielasek J. Mental health quality, outcome measurement, and improvement in Germany Current Opinion in Psychiatry. 22: 636-642. PMID 19730374 DOI: 10.1097/YCO.0b013e3283317c00  0.84
2009 Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Maier W, Lemke MR, Rüther E, et al. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophrenia Research. 113: 210-7. PMID 19560901 DOI: 10.1016/j.schres.2009.05.032  0.84
2009 Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, G. Schmidt L, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Degner D, Buchkremer G, Gastpar M, Möller HJ, et al. Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study European Psychiatry. 24: 501-506. PMID 19559572 DOI: 10.1016/j.eurpsy.2009.02.005  0.84
2009 Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, et al. Attitude towards adherence in patients with schizophrenia at discharge Journal of Psychiatric Research. 43: 1294-1301. PMID 19505697 DOI: 10.1016/j.jpsychires.2009.05.003  0.84
2009 Cordes J, Larisch R, Henning U, Thünker J, Werner C, Orozco G, Mayoral F, Rivas F, Auburger G, Tosch M, Rietschel M, Gaebel W, Müller HW, Klimke A. Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis. Depression and Anxiety. 26: E111-9. PMID 19288582 DOI: 10.1002/da.20405  0.84
2009 Wobrock T, Gruber O, Schneider-Axmann T, Wölwer W, Gaebel W, Riesbeck M, Maier W, Klosterkötter J, Schneider F, Buchkremer G, Möller HJ, Schmitt A, Bender S, Schlösser R, Falkai P. Internal capsule size associated with outcome in first-episode schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 259: 278-83. PMID 19224108 DOI: 10.1007/s00406-008-0867-y  0.84
2009 Jäger M, Riedel M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Buchkremer G, Gastpar M, et al. Prediction of symptom remission in schizophrenia during inpatient treatment. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 426-34. PMID 17853260 DOI: 10.1080/15622970701541054  0.84
2009 Wobrock T, Weinmann S, Falkai P, Gaebel W. Schizophrenia treatment based on practice guidelines | Leitlinienbasierte therapie der schizophrenie Nervenheilkunde. 28: 448-455.  0.84
Show low-probability matches.